Vaccinex, Inc. (VCNX): Capital Expenditures
Not updated since 2024-12-31. No annual report in US GAAP has been filed since. Companies that switch to IFRS reporting, as many foreign filers do, or stop filing are not updated here.
$22.0K
Year ended 2024-12-31
-11.7%
3-year compound annual growth
-22.4%
5-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | $22.0K | -67.2% | 2025-04-15, From 2024-01-01 |
| 2023-12-31 | $67.0K | -32.3% | 2025-04-15, From 2023-01-01 |
| 2022-12-31 | $99.0K | +209.4% | 2024-04-25, From 2022-01-01 |
| 2021-12-31 | $32.0K | -89.0% | 2023-03-31, From 2021-01-01 |
| 2020-12-31 | $290.0K | +271.8% | 2022-03-31, From 2020-01-01 |
| 2019-12-31 | $78.0K | -66.8% | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | $235.0K | +245.6% | 2020-03-09, From 2018-01-01 |
| 2017-12-31 | $68.0K | n/a | 2019-03-13, From 2017-01-01 |